Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
Pfizer and Allergan scrap $160 bln deal
Categorynews

Pfizer and Allergan scrap $160 bln deal

April 6, 2016 Off By Dino Mustafić
Pfizer and Allergan scrap $160 bln deal

Share this:

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook
  • Email a link to a friend (Opens in new window) Email
  • Share on LinkedIn (Opens in new window) LinkedIn

Related

TagsAllergan featured Pfizer
Primary Health Properties appoint new Directors
Biosimilars: More Treatment Options Are on the Way

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine
Go to mobile version